Emergent BioSolutions, Inc. (EBS)
7.85
-0.25
(-3.09%)
USD |
NYSE |
Apr 07, 16:00
7.86
+0.01
(+0.13%)
After-Hours: 20:00
Emergent BioSolutions Market Cap : 394.36M for April 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 90.72B |
| Eli Lilly & Co. | 834.48B |
| Penumbra, Inc. | 12.96B |
| Disc Medicine, Inc. | 2.587B |
| MetaVia, Inc. | 30.23M |
Market Cap Related Metrics
| PE Ratio | 9.183 |
| PS Ratio | 0.5649 |
| Price to Book Value | 0.7547 |
| Price to Free Cash Flow | 2.677 |
| Price | 7.85 |
| Earnings Yield | 10.89% |
| Operating PE Ratio | 3.840 |
| Normalized PE Ratio | 6.730 |